Ekobi Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Seed

  • Investors
  • 1

Ekobi General Information

Description

Manufacturer of medical equipment intended to focus on commercializing medical device products in the area of embolotherapy. The company offers a biodegradable embolic agent that is detectable by ultrasound for the treatment of malignant and non-malignant vascularized tumors, uterine fibroids, and enlarged prostates, enabling doctors and patients with a safe and effective alternative to surgery.

Contact Information

Website
www.imbiotechnologies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Advanced Technology Centre, Edmonton Research Park
  • Suite 215, 9650 - 20th Avenue
  • Edmonton, Alberta T6N 1G1
  • Canada
+1 (833)
Primary Industry
Biotechnology
Vertical(s)
Manufacturing, Oncology
Corporate Office
  • Advanced Technology Centre, Edmonton Research Park
  • Suite 215, 9650 - 20th Avenue
  • Edmonton, Alberta T6N 1G1
  • Canada
+1 (833)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ekobi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 13-Jun-2019 Completed Generating Revenue
1. Grant 13-Apr-2010 Completed Startup
To view Ekobi’s complete valuation and funding history, request access »

Ekobi Patents

  • 21

    Total Documents Applications and Grants

  • Total Patents Families

  • 7

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

Ekobi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018329237-A1 Sono-responsive embolic agents Inactive 07-Sep-2017
EP-3678712-A1 Sono-responsive embolic agents Inactive 07-Sep-2017
EP-3678712-A4 Sono-responsive embolic agents Inactive 07-Sep-2017
US-20200405856-A1 Sono-responsive embolic agents Pending 07-Sep-2017
WO-2019046955-A1 Sono-responsive embolic agents Inactive 07-Sep-2017 A61P9/00
To view Ekobi’s complete patent history, request access »

Ekobi Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ekobi Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Valhalla Private Capital Angel Group Minority
To view Ekobi’s complete investors history, request access »

Ready to get started?

Request a free trial

Ekobi FAQs

  • When was Ekobi founded?

    Ekobi was founded in 2008.

  • Where is Ekobi headquartered?

    Ekobi is headquartered in Edmonton, Canada.

  • What is the size of Ekobi?

    Ekobi has 3 total employees.

  • What industry is Ekobi in?

    Ekobi’s primary industry is Biotechnology.

  • Is Ekobi a private or public company?

    Ekobi is a Private company.

  • What is Ekobi’s current revenue?

    The current revenue for Ekobi is .

  • Who are Ekobi’s investors?

    Valhalla Private Capital has invested in Ekobi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process